A therapeutic composition for treating abnormal splicing caused by excessive kinase induction

Details for Australian Patent Application No. 2005200040 (hide)

International Classifications

Event Publications

20 January 2005 Complete Application Filed

Priority application(s): 60/534,978 09.01.04 US

28 April 2005 Amendment Made

The nature of the amendment is: Amend the name of the applicant to Tokyo Medical and Dental University

28 July 2005 Application Open to Public Inspection

Published as AU-B-2005200040

1 November 2007 Assignment before Grant

Tokyo Medical and Dental University The application has been assigned to KinoPharma, Inc.

27 January 2011 Application Accepted

Published as AU-B-2005200040

26 May 2011 Standard Patent Sealed

1 March 2012 Assignment Registered

KinoPharma, Inc. The patent has been assigned to JCR Pharmaceuticals Co., Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.